hCG
Selected male hypogonadotropic hypogonadism · US Pregnyl · IM
hCG is a gonadotropin used in endocrine and fertility care. This card selects one US label regimen for males. Selected male hypogonadotropic hypogonadism · US Pregnyl · IM.
Reviewed 2026-10-17. A source reference, not a personal treatment plan. Discuss treatment decisions with a qualified clinician.
Dose reference
| LABEL CONTEXT | Dose | Frequency | Context |
|---|---|---|---|
| Label option · weeks 1–3 | 500–1,000 USP units | 3 times weekly | Source |
| Same option · weeks 4–6 | 500–1,000 USP units | Twice weekly | Source |
The cited product is intramuscular. Do not apply this schedule to ovulation triggering, other hCG preparations or weight loss; the label does not support hCG as a weight-loss treatment.
Source context
This is one option listed for selected cases of male hypogonadotropic hypogonadism in the Pregnyl label. The same label lists other indication-specific regimens.
Reading the dose correctly
The cited product is intramuscular. Do not apply this schedule to ovulation triggering, other hCG preparations or weight loss; the label does not support hCG as a weight-loss treatment.
Download the chart
Further reading
References
Does the reference apply to other formulations?
Only the product, preparation and route named here are covered. A shared substance name does not establish an equivalent amount for another formulation.
Where can I read the wider evidence?
The linked myPeptides hCG monograph covers the mechanism, human and preclinical evidence, and important distinctions between related substances.